ストックスクリーナーアプリを入手
87.47
2.81%
-2.53
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
Assessing Insider Selling at ANI Pharmaceuticals: Confidence or Concern? - AInvest
The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - TradingView
Can ANI Pharmaceuticals Inc. Overcome Bearish SentimentBear Alert & Smart Allocation Stock Reports - sundaytimes.kr
Nikhil Lalwani, president of ANI Pharmaceuticals, sells $4.89m in stock - Investing.com Nigeria
Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock - Investing.com
ANI Pharmaceuticals director Haughey sells $1.66 million in stock - Investing.com
Ani Pharmaceuticals’ Cook sells $35k in stock - Investing.com
Ani Pharmaceuticals SVP Carey sells $4.3m in shares By Investing.com - Investing.com Canada
ANI Pharmaceuticals director Haughey sells $1.66 million in stock By Investing.com - Investing.com Canada
Ani Pharmaceuticals SVP Carey sells $4.3m in shares - Investing.com
Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals' Insider Sales: Liquidity or Lack of Confidence? - AInvest
Insider Selling at ANI Pharmaceuticals: Liquidity Moves or Lack of Confidence? - AInvest
Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock - Investing.com
Council approves plans for pharmaceutical manufacturing facility - veronapress.com
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance
ANI Pharmaceuticals Inc. Surpasses Analyst Target Price of $83.12 - AInvest
ANI Pharmaceuticals Reports Record Growth in Q2 2025 - TipRanks
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript - Insider Monkey
What technical models suggest about ANI Pharmaceuticals Inc.’s comebackFree Trade Setups With AI Powered Filters - Newser
Truist Securities Adjusts ANI Pharmaceuticals Price Target to $77 From $65, Maintains Hold Rating - MarketScreener
Historical volatility pattern of ANI Pharmaceuticals Inc. visualizedSmart Entry Watchlist with Daily Analysis - Newser
Trend analysis for ANI Pharmaceuticals Inc. this weekFree Profit Target Stock Opportunity Monitor - Newser
How high can ANI Pharmaceuticals Inc. stock goFundamental + Technical Combined Watchlist - Newser
When is the best time to exit ANI Pharmaceuticals Inc.Real-Time Signal Tracking with Entry Level - Newser
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Surges 25% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
ANI Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
ANI Pharmaceuticals Q2 2025 Earnings Call Highlights: Record Revenue, Raised Guidance, and Strong Growth - AInvest
Should I buy ANI Pharmaceuticals Inc. stock before earningsFree Swing Setup With Technical Confirmation - Newser
ANI Pharmaceuticals Q2 2025 Earnings Preview - MSN
ANI Pharmaceuticals: A High-Growth Biopharma Play with Rare Disease and Generics Synergy - AInvest
Is ANI Pharmaceuticals Inc. stock poised for growthLow Risk Stock Selection Strategy Guide - Newser
Assessing ANI Pharmaceuticals' (ANIP) Growth Trajectory in Rare Diseases and Generics Amid Strategic and Financial Headwinds - AInvest
ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates - MSN
Advanced analytics toolkit walkthrough for ANI Pharmaceuticals Inc.Free Buy Signal Based on Chart Analysis - Newser
ANI Pharmaceuticals Receives Buy Rating and Optimistic Price Target - timothysykes.com
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Average Recommendation of “Buy” by Brokerages - Defense World
Will ANI Pharmaceuticals Inc. rebound enough to break evenFree Short Term Buy List With Stop Protection - Newser
ANI Pharma Stock Shoots Through The Roof On Friday: CEO’s Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors - MSN
ANI Pharmaceuticals Inc. stock daily chart insightsFree Fundamental + Technical Hybrid Stock Tips - Newser
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 52-Week High Following Earnings Beat - Defense World
ANI Pharmaceuticals Inc (ANIP) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... By GuruFocus - Investing.com Canada
Published on: 2025-08-09 00:38:02 - Newser
ANI Pharmaceuticals' Q2 2025: Unpacking Contradictions in Cortrophin Growth and Market Dynamics - AInvest
ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright - Investing.com Canada
ANI: Q2 Earnings Snapshot - Norwalk Hour
Quantitative breakdown of ANI Pharmaceuticals Inc. recent moveFree Low Risk Buy Zone Opportunity Watch - Newser
Ani Pharmaceuticals shares rise 18.40% intraday after beating Q2 revenue and EPS estimates, raising FY forecast. - AInvest
ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright - TipRanks
Why ANI Pharmaceuticals (ANIP) Stock Is Up Today - TradingView
ANI Pharmaceuticals Stock Surges After Buy Rating and Strong Price Target - StocksToTrade
ANI Pharmaceuticals Surges as Buy Rating Hits Market - timothysykes.com
ANI Pharmaceuticals Surges 19%: What's Fueling This Explosive Move? - AInvest
Earnings call transcript: ANI Pharmaceuticals Q2 2025 earnings beat forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: ANI Pharmaceuticals Q2 2025 earnings beat forecasts - Investing.com
Transcript : ANI Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 08, 2025 - MarketScreener
ANI Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ani Pharmaceuticals stock hits 52-week high at 77.86 USD By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals stock hits 52-week high at 77.86 USD - Investing.com
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42 - TipRanks
2.80%
0.22%
大文字化:
|
ボリューム (24 時間):